Clinical Trial Update: Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a Phase 1/2 clinical trial evaluating the safety and efficacy of umbilical cord mesenchymal stem cell therapy for Duchenne M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Umbilical Cord Mesenchymal Stem Cell Therapy (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Shenzhen Beike Bio-Technology Co., Ltd. | Conditions: Duchenne Muscular Dystrophy | Phase 1, Phase 2 | Status: UNKNOWN